il cnr sfida di horizon 2020: di singole molecole allo di ... · dallo studio di singole molecole...
TRANSCRIPT
Dipartimento di Scienze Biomediche (DSB)
Il Dipartimento può contare su:•18 Istituti•800 Ricercatori•90 Tecnologi•430 Personale TA•> 500 Ricercatori associati•Oltre 100 brevetti attivi
Ambiti scientifici di riferimento e principali linee di ricerca del DSB• Cardiovascolare e malattie polmonari• Neuroscienze• Oncologia• Immunologia e malattie infettive• Medicina molecolare• Tecnologie biomediche• Genetica di popolazioni• Epidemiologia e health care research• Funzione, regolazione ed evoluzione dei genomi eucariotici• Struttura, funzione e progettazione di proteine, acidi nucleici e loro complessi
sopramolecolari• Meccanismi molecolari e segnali di controllo di proliferazione, differenziamento e
morte cellulare• Modelli animali per lo studio di processi fisio‐patologici e del comportamento• Meccanismi di adattamento a stress e biodiversità• Bioinformatica e biologia computazionale
• Gli Spin‐off attivi attualmente sono:• AMOLAB S.R.L• BYO RESEARCH S.R.L.• ECHOLIGHT S.R.L.• GLURES S.R.L.• LI‐TECH S.P.A.• MENERVA S.R.L.• QUIPU S.R.L• QualiMedLab S.R.L.• RE.D.D. S.R.L. Research for Drug Development
Aptamer-neomycin,Freire et al, Chem Commun 2007
Aptamer-thrombin, Russo Krauss et al, NAR 2011
Aptamers are single‐stranded nucleic acids (DNA, RNA) that assume three‐dimensional shapes to bind a given target molecule
High affinity and specificity for the target(Kd values in the range 10‐8‐10‐12 M)
Aptamers are generated by the SELEX technology (Systematic Evolution of Ligands byEXponential enrichment)
Dr. Vittorio de FranciscisResearch Director CNRIstituto per l’Endocrinologia e Oncologia Sperimentale "G. Salvatore"Via Pansini, 5‐ 80131 Naples Italy
Aptamers possess many advantages over antibodies as innovative tools in diagnosis, therapy and target validation
Aptamers vs Antibodies
Dr. Vittorio de FranciscisResearch Director CNRIstituto per l’Endocrinologia e Oncologia Sperimentale "G. Salvatore"Via Pansini, 5‐ 80131 Naples Italy
8
Il
Il DSB partecipa a numerose Infrastrutture Europee, ESFRI, tra cui:
BBMRI, Biobanks and Biomolecular ResourcesEATRIS, European Research Infrastructure for Translational MedicineELIXIR, Bioinformatic InfrastructureERA INSTRUMENTEurobioimaging, Clinical and Preclinical ImagingInfrafrontier, EMMA (Mouse Clinic)Instruct, INtegrated STRUCTural biologyLifeWatch, Research on Biodiversity
The Biocrystal Bacility offers to the CNR scientific network access to production and interpretation of crystals of biological macromolecules.The aim is to help the community of Italian users of European facilities and initiatives (ESRF, Biostruct‐X).We pursue a collaboration with ESRF, European Synchrotron Radiation Facility (ESRF, Grenoble, France), through joint training at the doctoral and post‐doctoral level at the ESRF facilities. The Facility has been established at the Institute of Molecular Biology and Pathology of CNR, in collaboration with the Dept. of Biochemistry of the “Sapienza” University of Rome.
Riferimento: Dr. Beatrice Vallone
10
• Al momento 4 finanziamenti ERC (3 advanced e 1 consolidator) sono andati a ricercatori associati al Dipartimento di Scienze Biomediche:
– Fabrizio D’Adda di Fagagna– IGM (Milano)– Rosario Rizzuto – IN (Padova)– Marco Sandri – IN (Padova)– Concetta Morrone ‐ IN (Pisa)
Protein structure analysisCrystallization
Structure determinationand refinement
X‐ray diffraction
At the Biocrystal Facility:
•Setting the biomedical or biotechnological project: defining objectives and critical points.•Consulting in the production and purification of proteins.•Robot crystallization screening and optimization with in‐house equipment and supporting application to European initiatives.•Synchrotron data collection.•Assistance and training, for the determination and analysis of the three‐dimensional structure of proteins and their functional complexes.
[email protected] Riferimento: Dr. Beatrice Vallone